Search research articles
Contact Us
Filters
Showing results (251-260 of 330) with videos related to
Page
of 33
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 19, 2016
The relative biological effectiveness of antiprotons
Michael H Holzscheiter, Jan Alsner, Niels Bassler, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 18, 2018
Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial
Line Brøndum, Jan Alsner, Brita Singers Sørensen, et al.
BMJ Open
|
November 17, 2025
At the epicentre: a qualitative study of how parents of a child with <i>de novo</i> retinoblastoma experience the diagnostic process and primary treatment
Stina Lou, Kathrine Carstensen, Pernille Aakjær Mikkelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2020
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial
Birgitte V Offersen, Jan Alsner, Hanne M Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 22, 2020
Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking
Jacob K Lilja-Fischer, Jesper G Eriksen, Jeanette B Georgsen, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 28, 2011
Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
Camilla Molich Hoff, Pernille Lassen, Jesper Grau Eriksen, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 30, 2025
Dual-tracer autoradiographic analysis of glucose metabolism and hypoxia in orthotopic and PDX tumor models
Morten Busk, Martin K Thomsen, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 6, 2023
Socioeconomic position and the pre-diagnostic interval among patients diagnosed with head and neck squamous cell carcinoma - a population-based study from DAHANCA
Maja Halgren Olsen, Thomas Maltesen, Pernille Lassen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 11, 2018
DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
Jens Overgaard, Camilla Molich Hoff, Hanne Sand Hansen, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 21, 2006
Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA
Hanne Primdahl, Anni Linnet Nielsen, Susanne Larsen, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 330) with videos related to
Sort By:
Page
of 33
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 19, 2016
The relative biological effectiveness of antiprotons
Michael H Holzscheiter, Jan Alsner, Niels Bassler, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 18, 2018
Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial
Line Brøndum, Jan Alsner, Brita Singers Sørensen, et al.
BMJ Open
|
November 17, 2025
At the epicentre: a qualitative study of how parents of a child with <i>de novo</i> retinoblastoma experience the diagnostic process and primary treatment
Stina Lou, Kathrine Carstensen, Pernille Aakjær Mikkelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2020
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial
Birgitte V Offersen, Jan Alsner, Hanne M Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 22, 2020
Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking
Jacob K Lilja-Fischer, Jesper G Eriksen, Jeanette B Georgsen, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 28, 2011
Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
Camilla Molich Hoff, Pernille Lassen, Jesper Grau Eriksen, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 30, 2025
Dual-tracer autoradiographic analysis of glucose metabolism and hypoxia in orthotopic and PDX tumor models
Morten Busk, Martin K Thomsen, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 6, 2023
Socioeconomic position and the pre-diagnostic interval among patients diagnosed with head and neck squamous cell carcinoma - a population-based study from DAHANCA
Maja Halgren Olsen, Thomas Maltesen, Pernille Lassen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 11, 2018
DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
Jens Overgaard, Camilla Molich Hoff, Hanne Sand Hansen, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 21, 2006
Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA
Hanne Primdahl, Anni Linnet Nielsen, Susanne Larsen, et al.
Page
of 33